Concepedia

Zhe Li

ZL

14

Publications

740

Citations

14

H-Index

2013

Active since

Affiliations

Global Blood Therapeutics (United States)(Current)

University of California, San Francisco

Institute for Neurodegenerative Disorders

Albert Einstein College of Medicine

Pfizer (United States)

Zhe Li is an author at Global Blood Therapeutics (United States) specializing in biochemistry, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2013–2023

14

Publications

14

<scp>GBT</scp>440 increases haemoglobin oxygen affinity, reduces sickling and prolongs <scp>RBC</scp> half‐life in a murine model of sickle cell disease

Donna Oksenberg, Kobina Dufu, Mira Patel et al. · British Journal of Haematology · 2016 · 232 citations · Full text

, , +19

Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin

Brian Metcalf, Chih-Yuan Chuang, Kobina Dufu et al. · ACS Medicinal Chemistry Letters · 2017 · 183 citations · Full text

Structures of human plasma β–factor XIIa cocrystallized with potent inhibitors

Alexey Dementiev, Abel Silva, Calvin Yee et al. · Blood Advances · 2018 · 52 citations · Full text

Biaryl Amides and Hydrazones as Therapeutics for Prion Disease in Transgenic Mice

Duo Lü, Kurt Giles, Zhe Li et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 45 citations · Full text

Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein Inhibitors

Zhe Li, James R. Partridge, Abel Silva‐Garcia et al. · ACS Medicinal Chemistry Letters · 2016 · 34 citations · Full text

Rows per page

1–5 of 14